Farcast Biodynamics
PrivateLast Round
Series C
Jul 11, 2018
Total Funding Raised
$80.6M
Company Overview
Farcast Biodynamics is a biotechnology company that develops a proprietary tumor microenvironment platform to predict cancer treatment responses and accelerate drug development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Farcast Biodynamics Comparables
Compare Farcast Biodynamics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kiyatec | 86% | |
| Xsphera Biosciences | 86% | |
| Nilogen Oncosystems | 85% |
Farcast Biodynamics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 11, 2018 | ||||
| Series B Extension | Aug 29, 2016 | ||||
| Series B | Oct 25, 2013 | ||||
| Series A | Apr 27, 2010 |
Farcast Biodynamics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series C, Series B Extension |
| Peak XV Partners | Series B Extension |
| Northpond Ventures | Series C |
| Sequoia Capital | Series C |
| Karnataka Information Technology Venture Fund | Series A |
| India Innovation Fund | Series B, Series A |
| Sands Capital | Series C, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 25, 2013
$7M round led by Tata Capital Innovations Fund.
- Apr 27, 2010
$7M round led by Accel.
Farcast Biodynamics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Farcast Biodynamics's valuation, stock price, and market status.
Is Farcast Biodynamics a public or private company?
Farcast Biodynamics is a private company.
What is the current stock price of Farcast Biodynamics?
Farcast Biodynamics is a private company with no public stock price. Caplight tracks Farcast Biodynamics's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Farcast Biodynamics worth (valuation)?
Valuation information for Farcast Biodynamics is not publicly available.
Can I buy Farcast Biodynamics stock?
Farcast Biodynamics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Farcast Biodynamics's last funding round?
Farcast Biodynamics's most recent funding round was Series C on July 11, 2018.
Who are the main investors in Farcast Biodynamics?
Key investors in Farcast Biodynamics include Peak XV Partners, Northpond Ventures, Sands Capital.
Will Farcast Biodynamics IPO soon?
No public IPO plans have been announced for Farcast Biodynamics.
How can I track Farcast Biodynamics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Farcast Biodynamics's secondary market activity and sign up for updates.